UnitedHealth Group (UNH, Health insurers) Stock Valuation & Fair Value Mixed on our tests
UnitedHealth Group (UNH, Health insurers) trades at a current P/E of 19.9, about 13% above its historical normal valuation, with a forward growth estimate of 14.9% and a PEG of 1.33. Analysts' one-year estimates have been hit 73% of the time. Priced at its historical normal P/E of 17.6 on the same blended earnings, the 2026-10-09 close of $379.30 corresponds to about $336 a share. This is a valuation reference, not a price target.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.
- Price $378.52 at the 2026-10-12 close, 1.0% above the 20-day average ($374.66) and 2.2% below the 50-day ($387.05).
- RSI (14) at 49.0.
- 52-week range $255.97 to $433.68: the price is 12.7% below the high and 47.9% above the low.
- At its last earnings report the options market priced a 6.1% move.
The Street vs SeerForecast
Wall Street's mean price target for UNH is $481.72 across 25 analysts, 27.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating moved from trading above its usual valuation (2026-06-03) to mixed on our tests (2026-10-12).
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 39 weeks
Earnings moves: UNH moved more than the options market implied in 0 of 1 recent tracked reports.
Frequently asked questions
Is UnitedHealth Group stock overvalued?
At a current P/E of 19.9 versus its historical normal P/E of 17.6, UnitedHealth Group trades about 13% above its typical valuation, with a PEG of 1.33 on 14.9% forward growth. tickerseer currently rates it mixed on our tests.
What is UnitedHealth Group's fair value and PEG?
UnitedHealth Group trades at a current P/E of 19.9 against a historical normal P/E of 17.6, a PEG of 1.33, and a forward growth estimate of 14.9%. Priced at its historical normal P/E of 17.6 on the same blended earnings, the 2026-10-09 close of $379.30 corresponds to about $336 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of UnitedHealth Group changed?
tickerseer's rating moved from trading above its usual valuation (2026-06-03) to mixed on our tests (2026-10-12).
What is the analyst price target for UnitedHealth Group?
The mean Wall Street price target for UnitedHealth Group is $481.72 across 25 analysts, 27.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health insurers. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.